top of page
GP Psychiatrist Collaboration Trends in ADHD Care

GP Psychiatrist Collaboration Trends in ADHD Care

Writer: Dr Iqbal A Mohiuddin
Dr Iqbal A Mohiuddin
Nov 7
5 min read

A private ADHD diagnosis is only the beginning of the care pathway. For many adults, the next questions are practical: who will prescribe medication, how will physical health monitoring be arranged, and what happens if treatment needs to change? GP psychiatrist collaboration trends are increasingly focused on answering these questions earlier, with clearer clinical information, realistic shared-care discussions and better continuity between specialist and primary care.

For patients, good collaboration can reduce uncertainty at a time when they may already have spent years seeking answers. It also supports safer prescribing and makes it easier for each clinician to understand their role. However, collaboration is not automatic, and a shared-care arrangement cannot be assumed. It depends on your individual circumstances, the quality of the specialist assessment and your GP practice’s local policies and clinical capacity.

Why GP-psychiatrist collaboration matters

GPs provide broad, ongoing medical care. Psychiatrists provide specialist diagnostic assessment and treatment planning for mental health conditions, including adult ADHD, anxiety, depression, bipolar disorder, OCD, PTSD and psychosis. When these roles are connected appropriately, patients are less likely to feel that they are repeating their history or managing complex clinical information alone.

This is especially relevant in ADHD care. Medication may require careful titration, meaning that the dose is adjusted gradually while benefits, side effects, blood pressure, pulse, weight, sleep and mental wellbeing are reviewed. A consultant psychiatrist may lead this specialist phase, while a GP may later be asked to continue a stable prescription under shared care. The arrangement should be clinically safe, documented and acceptable to everyone involved.

Collaboration also matters where ADHD sits alongside other concerns. Symptoms such as poor concentration, restlessness, low mood, trauma responses, substance misuse, sleep difficulties or anxiety can overlap. A thoughtful psychiatric assessment considers the whole picture rather than treating a questionnaire score as a diagnosis in isolation. Your GP’s medical history, current medication and physical health information can be valuable parts of that picture.

GP psychiatrist collaboration trends shaping patient care

Earlier communication, not a letter at the end

One positive trend is the move towards discussing GP involvement from the start of private treatment, rather than raising it only after a diagnosis has been made. Patients benefit when they understand that a specialist report may be sent to their GP, usually with their consent, and what it is likely to contain.

A useful medical summary explains the assessment findings, diagnosis where appropriate, relevant risks, treatment recommendations, medication history and monitoring requirements. It should be sufficiently clear for a GP to make an informed decision, without expecting them to take responsibility for a treatment plan they have not agreed to provide.

For patients, this early transparency prevents a common misunderstanding: a private prescription does not automatically mean that NHS GP prescribing will follow. Some practices may consider shared care once treatment is stable and documentation is complete; others may not be able to do so. Local commissioning arrangements, practice policy and clinical judgement can all affect the outcome.

More detailed shared-care documentation

Shared-care requests are becoming more structured, particularly for medicines used in ADHD treatment. GPs need confidence about the diagnosis, the medicine prescribed, the titration outcome, the intended dose, required physical observations, follow-up arrangements and who to contact if concerns arise.

This level of detail is not bureaucracy for its own sake. It helps avoid gaps in care. If a patient develops troublesome side effects, becomes pregnant, starts another medicine or experiences a significant deterioration in mental health, both the GP and psychiatrist need to know where responsibility sits and how quickly a review can be arranged.

The strongest plans are specific but flexible. They state what is stable now while recognising that treatment may need reassessment later. ADHD medication is not a one-size-fits-all intervention, and a good response should be judged by meaningful changes in daily life, such as attention, organisation, emotional regulation, work or study functioning, relationships and safety.

A greater focus on physical health monitoring

Psychiatric prescribing has always required attention to physical health, but collaboration is increasingly centred on making monitoring visible and practical. This is particularly relevant for stimulant and non-stimulant ADHD medication, where baseline information and ongoing observations may be needed depending on the medicine and the individual.

A psychiatrist may request information about cardiovascular history, blood pressure, pulse, weight, sleep, other medicines and relevant family history before prescribing. In some circumstances, further medical assessment may be appropriate. The goal is not to create unnecessary barriers, but to make decisions that reflect the patient’s full health profile.

GPs are well placed to support routine observations because they know a patient’s wider medical history. Equally, a specialist should remain available to advise on psychiatric medication decisions, particularly during titration or when symptoms become more complex. Dividing these tasks clearly is safer than assuming that one clinician has all the information.

Digital records, with consent and boundaries

Patients increasingly expect information to move efficiently between services. Secure electronic correspondence and prompt medical summaries can improve continuity, particularly for people living in Luton, London, Hertfordshire, Bedfordshire or further afield who may see a private psychiatrist separately from their usual GP practice.

Yet speed should not come at the expense of confidentiality. Patients should understand what information is being shared, why it is relevant and whether they consent to their GP receiving it. There are occasions when a patient may prefer limited communication, but this can affect how safely a medication plan can be managed. A compassionate clinician will explain the implications without pressure and help the patient make an informed choice.

What shared care can and cannot offer

Shared care can be helpful when a diagnosis is established, medication has been titrated to a stable and effective dose, monitoring requirements are clear and the GP practice is willing to participate. It may make follow-up prescribing more convenient and allow the GP to remain connected to the patient’s overall health needs.

It is not a guarantee of NHS prescribing, nor does it mean specialist input is no longer needed. Some patients need ongoing psychiatric reviews because their medication is changing, symptoms are not stable, there are co-existing mental health conditions or risk needs to be considered. Others may prefer to remain under private prescribing for continuity, even where shared care could be explored.

A refusal of shared care should not be interpreted as a judgement about the validity of a diagnosis or the patient’s need for support. GP practices must work within their own clinical governance arrangements and capacity. The constructive next step is to ask for a clear explanation, then discuss alternative prescribing and review options with the psychiatrist.

How patients can support a smoother conversation

Patients do not need to act as the clinical go-between, but being prepared can make discussions easier. Before an assessment, it can help to obtain an up-to-date GP medical summary where possible, including current medication, relevant diagnoses and physical health information. Be open about previous mental health treatment, substance use, sleep, cardiovascular symptoms and any medication side effects.

If ADHD medication is recommended, ask practical questions early. Who will prescribe during titration? What observations will be needed? When will the specialist review progress? At what point, if any, might shared care be requested? What happens if your GP does not accept the arrangement?

At IamPsychiatry, consultant-led assessment and treatment planning are designed to provide patients and GPs with clear clinical information, including a medical summary after assessment where consent is provided. This supports informed conversations about diagnosis, medication, therapy, lifestyle factors and follow-up, while recognising that every patient and GP practice has different needs.

A partnership built around recovery

The best GP-psychiatrist relationship is not about transferring a patient from one service to another. It is about creating a clear, respectful plan around the person receiving care. For some, that will mean short-term specialist treatment followed by GP-supported prescribing. For others, ongoing psychiatric review will remain the safest option.

If you are considering a private psychiatric assessment, ask how communication with your GP will be handled before you begin. Clear expectations at the outset can make treatment feel less fragmented and leave more room for what matters most: building a plan that helps you recover and enjoy life.

 
 
 

Comments


Heading 1

bottom of page